Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096107 · ClinicalTrials.gov registry record · Phase 4
Novartis Everolimus Transition
A Phase 4 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT02096107 is a Phase 4 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 60 participants.
The verdict
NCT02096107, a Phase 4 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
Transition from tacrolimus based triple therapy with Mycophenolate Mofetil (MMF) and steroids in stable renal transplant patients to low intensity tacrolimus, everolimus and prednisone will be associated with improvement in Glomular Filtration Rate (GFR) and allograft fibrosis.
Interventions
- OTHER Standard of Care
- DRUG Everolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02096107
The ClinicalTrials.gov registry entry for NCT02096107 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02096107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02096107 about?
NCT02096107 is a clinical study titled "Novartis Everolimus Transition". Transition from tacrolimus based triple therapy with Mycophenolate Mofetil (MMF) and steroids in stable renal transplant patients to low intensity tacrolimus, everolimus and prednisone will be associated with improvement in Glomular Filtration Rate (GFR) and allograft fibrosis.
What is the current status of trial NCT02096107?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2014-02. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02096107?
The interventions under investigation include: Standard of Care (OTHER), Everolimus (DRUG).
Who is sponsoring clinical trial NCT02096107?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.